Description:
ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF
ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
| Class |
Disorders of Lipid Metabolism |
|
Cell Type
|
Fibroblast
|
|
Tissue Type
|
Skin
|
|
Transformant
|
Untransformed
|
|
Race
|
White
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
| |
| Gene |
ACADS |
| Chromosomal Location |
12q22-qter |
| Allelic Variant 1 |
606885.0006; SCAD DEFICIENCY |
| Identified Mutation |
ARG147TRP; Gregersen et al. (1998) found a 511C-T mutation (resulting in an arg147-to-trp amino acid substitution) in 13 of 130 and 15 of 67 625G polymorphic alleles, respectively, of normal controls and patients with elevated EMA excretion; they never found it in association with the 625A variant. This overrepresentation of the haplotype 511T-625G among the common 625G alleles in patients compared with controls was significant (P less than 0.02), suggesting that the allele 511T-625G, like 511C-625A, confers susceptibility to ethylmalonicaciduria. Gregersen et al. (1998) concluded that ethylmalonicaciduria, a commonly detected biochemical phenotype, is a complex multifactorial/polygenic condition where, in addition to the role of SCAD susceptibility alleles, other genetic and environmental factors are involved.
|
| |
| Gene |
ACADS |
| Chromosomal Location |
12q22-qter |
| Allelic Variant 2 |
606885.0006; SCAD DEFICIENCY |
| Identified Mutation |
ARG147TRP; Gregersen et al. (1998) found a 511C-T mutation (resulting in an arg147-to-trp amino acid substitution) in 13 of 130 and 15 of 67 625G polymorphic alleles, respectively, of normal controls and patients with elevated EMA excretion; they never found it in association with the 625A variant. This overrepresentation of the haplotype 511T-625G among the common 625G alleles in patients compared with controls was significant (P less than 0.02), suggesting that the allele 511T-625G, like 511C-625A, confers susceptibility to ethylmalonicaciduria. Gregersen et al. (1998) concluded that ethylmalonicaciduria, a commonly detected biochemical phenotype, is a complex multifactorial/polygenic condition where, in addition to the role of SCAD susceptibility alleles, other genetic and environmental factors are involved.
|
| Remarks |
Clinically affected; hypotonia; hypoglycemia; developmental delay; ethylmalonic aciduria; EMA elevated in urine; elevated butyryl and carnitine; deficient small-chain Acyl-CoA dehydrogenase by electron-transferring flavoprotein reduction assay; undetectable small-chain Acyl-CoA dehydrogenase activity in fibroblasts (undetectable represents <10% of control SCAD activity); donor subject is homozygous for a C>T transition at nucleotide 511 of the ACADS gene [511C>T] resulting in a substitution of tryptophan for arginine at codon 147 [Arg147Trp (R147W)]; exon counting and quantitative PCR have not been done to confirm homozygosity |
| Corydon MJ, Vockley J, Rinaldo P, Rhead WJ, Kjeldsen M, Winter V, Riggs C, Babovic-Vuksanovic D, Smeitink J, De Jong J, Levy H, Sewell AC, Roe C, Matern D, Dasouki M, Gregersen N, Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency. Pediatr Res49(1):18-23 2001 |
| PubMed ID: 11134486 |
| dbSNP |
dbSNP ID: 13952 |
| Gene Cards |
ACADS |
| Gene Ontology |
GO:0004085 butyryl-CoA dehydrogenase activity |
|
GO:0005739 mitochondrion |
|
GO:0006091 energy pathways |
|
GO:0006118 electron transport |
|
GO:0006631 fatty acid metabolism |
|
GO:0006635 fatty acid beta-oxidation |
|
GO:0016491 oxidoreductase activity |
| NCBI Gene |
Gene ID:35 |
| NCBI GTR |
201470 ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD |
|
606885 ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS |
| OMIM |
201470 ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD |
|
606885 ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS |
| Omim Description |
ACADS DEFICIENCY, INCLUDED |
| |
ACYL-CoA DEHYDROGENASE, C-2 TO C-3 SHORT CHAINACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF, INCLUDED |
| |
ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS |
| |
LIPID-STORAGE MYOPATHY SECONDARY TO SHORT-CHAIN ACYL-CoA DEHYDROGENASEDEFICIENCY, INCLUDED |
| |
SCAD DEFICIENCY, INCLUDED |
| |
SCADH DEFICIENCY, INCLUDED |
| |
SHORT-CHAIN ACYL-CoA DEHYDROGENASE; SCAD |
| Split Ratio |
1:3 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|